+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 4q91 | ||||||
---|---|---|---|---|---|---|---|
タイトル | Crystal structure of C16A/K12V/C117V/P134V mutant of human acidic fibroblast growth factor | ||||||
要素 | Fibroblast growth factor 1 | ||||||
キーワード | PROTEIN BINDING / Beta-trefoil / growth factor / FGFR binding / heparin binding / extracellular matrix | ||||||
機能・相同性 | 機能・相同性情報 mesonephric epithelium development / branch elongation involved in ureteric bud branching / regulation of endothelial tube morphogenesis / FGFR3b ligand binding and activation / FGFR2b ligand binding and activation / regulation of endothelial cell chemotaxis to fibroblast growth factor / FGFR2c ligand binding and activation / Activated point mutants of FGFR2 / Phospholipase C-mediated cascade; FGFR2 / Signaling by activated point mutants of FGFR3 ...mesonephric epithelium development / branch elongation involved in ureteric bud branching / regulation of endothelial tube morphogenesis / FGFR3b ligand binding and activation / FGFR2b ligand binding and activation / regulation of endothelial cell chemotaxis to fibroblast growth factor / FGFR2c ligand binding and activation / Activated point mutants of FGFR2 / Phospholipase C-mediated cascade; FGFR2 / Signaling by activated point mutants of FGFR3 / FGFR3c ligand binding and activation / Phospholipase C-mediated cascade; FGFR3 / positive regulation of cholesterol biosynthetic process / fibroblast growth factor receptor binding / FGFR4 ligand binding and activation / FGFR1b ligand binding and activation / Phospholipase C-mediated cascade; FGFR4 / Signaling by activated point mutants of FGFR1 / organ induction / FGFR1c ligand binding and activation / Downstream signaling of activated FGFR1 / Phospholipase C-mediated cascade: FGFR1 / S100 protein binding / positive regulation of hepatocyte proliferation / positive regulation of intracellular signal transduction / Signaling by FGFR2 IIIa TM / PI-3K cascade:FGFR2 / PI-3K cascade:FGFR3 / PI-3K cascade:FGFR4 / positive regulation of sprouting angiogenesis / PI-3K cascade:FGFR1 / positive regulation of cell division / PI3K Cascade / fibroblast growth factor receptor signaling pathway / anatomical structure morphogenesis / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR3 / SHC-mediated cascade:FGFR4 / SHC-mediated cascade:FGFR1 / FRS-mediated FGFR2 signaling / FRS-mediated FGFR3 signaling / Signaling by FGFR2 in disease / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / FRS-mediated FGFR1 signaling / Signaling by FGFR1 in disease / Hsp70 protein binding / activation of protein kinase B activity / regulation of cell migration / positive regulation of endothelial cell migration / extracellular matrix / epithelial cell proliferation / animal organ morphogenesis / Negative regulation of FGFR2 signaling / Negative regulation of FGFR3 signaling / lung development / Negative regulation of FGFR4 signaling / Negative regulation of FGFR1 signaling / growth factor activity / positive regulation of MAP kinase activity / wound healing / positive regulation of angiogenesis / Constitutive Signaling by Aberrant PI3K in Cancer / integrin binding / PIP3 activates AKT signaling / heparin binding / cell cortex / cellular response to heat / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / RAF/MAP kinase cascade / angiogenesis / positive regulation of ERK1 and ERK2 cascade / cell differentiation / positive regulation of cell migration / positive regulation of cell population proliferation / positive regulation of gene expression / signal transduction / positive regulation of transcription by RNA polymerase II / extracellular space / extracellular region / nucleoplasm / nucleus / cytosol / cytoplasm 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) | ||||||
手法 | X線回折 / 分子置換 / 解像度: 1.799 Å | ||||||
データ登録者 | Xia, X. / Blaber, M. | ||||||
引用 | ジャーナル: J.Pharm.Sci. / 年: 2015 タイトル: Mutation choice to eliminate buried free cysteines in protein therapeutics. 著者: Xia, X. / Longo, L.M. / Blaber, M. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 4q91.cif.gz | 76.7 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb4q91.ent.gz | 58.5 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 4q91.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 4q91_validation.pdf.gz | 458.5 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 4q91_full_validation.pdf.gz | 461.6 KB | 表示 | |
XML形式データ | 4q91_validation.xml.gz | 16.9 KB | 表示 | |
CIF形式データ | 4q91_validation.cif.gz | 24.6 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/q9/4q91 ftp://data.pdbj.org/pub/pdb/validation_reports/q9/4q91 | HTTPS FTP |
-関連構造データ
-リンク
-集合体
登録構造単位 |
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||
2 |
| |||||||||
単位格子 |
| |||||||||
Components on special symmetry positions |
|
-要素
#1: タンパク質 | 分子量: 16622.637 Da / 分子数: 2 / 断片: UNP residues 16-155 / 変異: K12V/C16A/C117V/P134V / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: FGF1, FGFA / プラスミド: pET21a(+) / 発現宿主: Escherichia coli (大腸菌) / 株 (発現宿主): BL21(DE3) / 参照: UniProt: P05230 #2: 化合物 | ChemComp-FMT / #3: 化合物 | ChemComp-PO4 / | #4: 水 | ChemComp-HOH / | |
---|
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 2.91 Å3/Da / 溶媒含有率: 57.66 % |
---|---|
結晶化 | 温度: 298 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 7.5 詳細: 3.4 M sodium formate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K |
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: 回転陽極 / タイプ: RIGAKU RUH3R / 波長: 1.541 Å |
検出器 | タイプ: RIGAKU RAXIS IV++ / 検出器: IMAGE PLATE / 詳細: Osmic confocal mirrors |
放射 | モノクロメーター: Multi-layer mirrors / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.541 Å / 相対比: 1 |
反射 | 解像度: 1.799→58.927 Å / Num. all: 36584 / Num. obs: 36344 / % possible obs: 99.4 % / Observed criterion σ(I): 2 / 冗長度: 6 % |
反射 シェル | 最高解像度: 1.799 Å |
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 分子置換 / 解像度: 1.799→36.13 Å / SU ML: 0.18 / σ(F): 1.35 / 位相誤差: 18.76 / 立体化学のターゲット値: ML
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | 減衰半径: 0.9 Å / VDWプローブ半径: 1.11 Å / 溶媒モデル: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.799→36.13 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル |
|